Unstable angina/ NSTEMI resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 36: Line 36:
{{familytree  | | | | | C01 | | | | | | C02 | | C01= LOW RISK <br> Initial conservative strategy| C02= HIGH RISK <br> Initial invasive strategy}}
{{familytree  | | | | | C01 | | | | | | C02 | | C01= LOW RISK <br> Initial conservative strategy| C02= HIGH RISK <br> Initial invasive strategy}}
{{familytree  | | | | | |!| | | | | | | |!| | | }}
{{familytree  | | | | | |!| | | | | | | |!| | | }}
{{familytree  | | | | | D01 | | | | | | D02 | | D01=  
{{familytree  | | | | | D01 | | | | | | D02 | | D01= ❑ Administer 300mg of copidogrel <br> ❑ Administer fondoparinaux or UFH in case of renal failure
❑ Administer 300mg of copidogrel <br>
|D02= ❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban) <br> OR <br> ❑ Administer Bivalirudin}}
❑ Administer fondoparinaux or UFH in case of renal failure|
D02= ❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban) <br>
OR
❑ Administer Bivalirudin}}
{{familytree  | | | | | |!| | | | | | | |!| | | }}
{{familytree  | | | | | |!| | | | | | | |!| | | }}
{{familytree  | | | | | E01 | | | | | | E02 | | E01= Perform a Stress test | E02= Angiography  }}
{{familytree  | | | | | E01 | | | | | | E02 | | E01= Perform a Stress test | E02= Angiography  }}
Line 47: Line 43:
{{familytree  | | | F01 | | F02 | | F03 | | F04 | | F01= LOW RISK | F02= HIGH RISK | F03= NEGATIVE | F04= POSITIVE}}
{{familytree  | | | F01 | | F02 | | F03 | | F04 | | F01= LOW RISK | F02= HIGH RISK | F03= NEGATIVE | F04= POSITIVE}}
{{familytree  | | | |!| | | |!| | | |!| | | |!| }}
{{familytree  | | | |!| | | |!| | | |!| | | |!| }}
{{familytree  | | | G01 | | |!| | | G02 | | |!| G01= | G02= ❑ Continue Aspirin <br>
{{familytree  | | | G01 | | |!| | | G02 | | |!| G01= Recurrent symptoms <br>  | G02= ❑ Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br>
❑ Continue with clopidrogel or tucagelor for 12 months <br>
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}}
❑ Discontinue with GP inhibitors <br>
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}}
{{familytree  | |,|-|^|-|.| |!| | | | | | | |!| }}
{{familytree  | |,|-|^|-|.| |!| | | | | | | |!| }}
{{familytree  | H01 | | H02 |!| | | | | | | |!| H01= | H02=}}
{{familytree  | H01 | | H02 |!| | | | | | | |!| H01= NO | H02= ❑ heart faillure <br> ❑ serious arrhythmias}}
{{familytree  | |!| | | |!| |!| | | | | |,|-|^|-|.| }}
{{familytree  | |!| | | |!| |!| | | | | |,|-|^|-|.| }}
{{familytree  | I01 | | |!| |!| | | | | I02 | | I03 | | | I01= | I02= | I03= }}
{{familytree  | I01 | | |!| |!| | | | | I02 | | I03 | | | I01= | I02= | I03= }}
Line 58: Line 52:
{{familytree  | | | | |,|-|^|-|.| | | | | | | | }}
{{familytree  | | | | |,|-|^|-|.| | | | | | | | }}
{{familytree  | | | | K01 | | K02 | | | | | K01=  ❑ Continue Aspirin <br>
{{familytree  | | | | K01 | | K02 | | | | | K01=  ❑ Continue Aspirin <br>
❑ Continue with clopidrogel or tucagelor for 12 months <br>
❑ Continue with clopidrogel or ticagelor for 12 months <br>
❑ Discontinue with GP inhibitors <br>
❑ Discontinue with GP inhibitors <br>
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)| K02=}}
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)| K02=}}

Revision as of 16:51, 27 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Definition

Causes

Life Threatening Causes

Common Causes

Management

Diagnosis

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Treatment

 
 
 
 
 
 
 
 
❑ Administer 300mg Aspirin immediately after hospital admission

❑ Administer oxygen in patients with saturation <90%
❑ Administer nitroglycerine sub-lingual ADD DOSES
❑ Administer morphine IV initial dose 2-4mg with increments of 2-8mg every 5 to 15 minutes
❑ Administer beta-blockers to all patients without contraindications
❑ Administer statins, atorvastatine 80mg

❑ Initiate anti thrombotic therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determine Risk of adverse coronary event (TIMI)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW RISK
Initial conservative strategy
 
 
 
 
 
HIGH RISK
Initial invasive strategy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Administer 300mg of copidogrel
❑ Administer fondoparinaux or UFH in case of renal failure
 
 
 
 
 
❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban)
OR
❑ Administer Bivalirudin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform a Stress test
 
 
 
 
 
Angiography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW RISK
 
HIGH RISK
 
NEGATIVE
 
POSITIVE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recurrent symptoms
 
 
 
 
 
 
❑ Continue Aspirin
❑ Continue with clopidrogel or ticagelor for 12 months
❑ Discontinue with GP inhibitors
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO
 
❑ heart faillure
❑ serious arrhythmias
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Continue Aspirin

❑ Continue with clopidrogel or ticagelor for 12 months
❑ Discontinue with GP inhibitors

❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

References


Template:WikiDoc Sources